We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.40 | 0.54% | 75.00 | 74.60 | 75.00 | 75.20 | 74.80 | 74.80 | 256 | 11:54:50 |
Hot Features
Premium
RNS Number:2346U
CeNeS Pharmaceuticals PLC
14 January 2004
CENES PHARMACEUTICALS PLC ("the Company")
HOLDING IN COMPANY
The Company received notification today that a client of ISIS Asset Management
plc, Active Capital Trust, following the disposal of 2,500,000 ordinary shares
of 1p each between 12th and 13th January 2004, has an interest in 13,700,000
ordinary shares of 1p each in the capital of the Company representing 5.47 per
cent. of the issued share capital of the Company.
Further information
Neil Clark, CeNeS Pharmaceuticals plc 01223 266 466
14 January 2004
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSSSRSSRAAAR
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
